Clínica Baviera, S.A. (BME: CBAV)

Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	243.31	227.07	198.45	173.25	122.63	124.33
Revenue Growth (YoY)	14.64%	14.42%	14.55%	41.28%	-1.37%	13.76%
Cost of Revenue	122.92	115.1	96.55	84.05	64.23	62.39
Gross Profit	120.39	111.97	101.9	89.2	58.4	61.95
Selling, General & Admin	12.09	12.09	11.69	9.87	7.82	9.41
Other Operating Expenses	36.69	32.86	33.25	25.77	17.2	21
Operating Expenses	67.34	61.93	59.94	49.73	38.57	43.63
Operating Income	53.05	50.04	41.96	39.46	19.83	18.32
Interest Expense	-0.62	-0.57	-0.42	-0.46	-0.54	-0.59
Interest & Investment Income	0.25	0.15	0.07	0	0.01	0
Earnings From Equity Investments	-0.01	-0.01	-0.06	-0.03	0.2	0.08
Currency Exchange Gain (Loss)	0.02	0.01	-0	-0	-	-
Other Non Operating Income (Expenses)	0.28	0.07	-0.4	-0.04	-0	-0.01
EBT Excluding Unusual Items	52.97	49.68	41.15	38.93	19.51	17.79
Asset Writedown	0.06	-0.03	-0.47	-0.03	-	-
Other Unusual Items	-	-	-	-	0.68	-
Pretax Income	53.02	49.65	40.68	38.9	20.19	17.79
Income Tax Expense	13.75	12.92	10.53	10.97	6.05	4.89
Earnings From Continuing Operations	39.27	36.73	30.15	27.93	14.13	12.9
Net Income to Company	39.27	36.73	30.15	27.93	14.13	12.9
Minority Interest in Earnings	-0.86	-0.76	-0.63	-0.54	-0.19	-0.11
Net Income	38.41	35.97	29.52	27.39	13.94	12.79
Net Income to Common	38.41	35.97	29.52	27.39	13.94	12.79
Net Income Growth	22.49%	21.86%	7.77%	96.46%	8.97%	8.19%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16	16
Shares Change (YoY)	0.30%	-0.00%	-	0.01%	-0.01%	-0.01%
EPS (Basic)	2.36	2.21	1.81	1.68	0.86	0.78
EPS (Diluted)	2.36	2.21	1.81	1.68	0.86	0.78
EPS Growth	22.13%	21.86%	7.77%	96.43%	8.97%	8.20%
Free Cash Flow	39.06	35.13	39.35	36.28	23.64	16.21
Free Cash Flow Per Share	2.40	2.16	2.41	2.23	1.45	0.99
Dividend Per Share	1.570	1.570	1.300	1.030	0.552	-
Dividend Growth	96.25%	20.77%	26.21%	86.59%	-	-
Gross Margin	49.48%	49.31%	51.35%	51.49%	47.62%	49.82%
Operating Margin	21.80%	22.04%	21.14%	22.78%	16.17%	14.73%
Profit Margin	15.79%	15.84%	14.87%	15.81%	11.37%	10.29%
Free Cash Flow Margin	16.05%	15.47%	19.83%	20.94%	19.28%	13.04%
EBITDA	71.09	66.5	56.76	53.35	33.21	31.34
EBITDA Margin	29.22%	29.29%	28.60%	30.80%	27.08%	25.21%
D&A For EBITDA	18.04	16.46	14.8	13.89	13.38	13.02
EBIT	53.05	50.04	41.96	39.46	19.83	18.32
EBIT Margin	21.80%	22.04%	21.14%	22.78%	16.17%	14.73%
Effective Tax Rate	25.93%	26.02%	25.89%	28.20%	29.99%	27.47%
Advertising Expenses	-	10.31	9.86	8.42	5.79	8.22

Source: S&P Capital IQ. Standard template. Financial Sources.